Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2002
12/11/2002EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence
12/11/2002EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions
12/10/2002US6492562 Invention also relates to novel intermediates and the resulting modified polyketides and antibiotics.
12/10/2002US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002US6492399 Pharmaceutical compositions and methods for use
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002US6492364 Triazolo and derivatives as chemokine inhibitors
12/10/2002US6492356 Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
12/10/2002US6491989 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures
12/09/2002WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002WO2002097116A2 Delivery system for nucleic acids
12/05/2002WO2002096901A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/05/2002WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002WO2002096886A1 Pyrimidine derivatives
12/05/2002WO2002096885A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002WO2002096884A2 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
12/05/2002WO2002096882A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
12/05/2002WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002WO2002096872A1 Substituted imidates as pesticidal agents
12/05/2002WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002WO2002096427A1 Pyrimidine derivatives as selective inhibitors of cox-2
12/05/2002WO2002096367A2 Targeted multivalent macromolecules
12/05/2002WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002WO2002062798A3 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
12/05/2002WO2002056681A3 Novel intermediates and process to pyrimidinedione herbicides
12/05/2002US20020183519 Antithrombotic carboxylic acid amides
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor
12/05/2002US20020183365 Therapy or ameliorating an indication of the invention in an animal, including a human, comprising administering heteroaryl compond
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002US20020183340 Administering to the patient an effective amount of 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline for therapy of colorectal cancer
12/05/2002US20020183339 Medicament for prevention and treatment of dermatitis having chymase inhibitor as effective ingredient
12/05/2002US20020183338 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
12/05/2002US20020183335 2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators
12/05/2002US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
12/05/2002US20020182625 Nucleotide sequence labelling compoumd four use as tool in genetic engineering
12/05/2002DE10125963A1 Substituierte Imidate Substituted Imidates
12/05/2002CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002CA2448305A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002CA2448192A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002CA2445647A1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/04/2002EP1261679A1 Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds
12/04/2002EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses
12/04/2002EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002EP1111993A4 Fused-benzene derivatives useful as herbicides
12/04/2002CN1383425A Uracil substituted phenyl sulfamoyl carboxamides
12/04/2002CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/04/2002CN1382687A Process for directly synthesizing pyrimidine, 1,3,5-triazine, phthalocyanine and polynitrile from nitrile
12/03/2002US6489483 Reacting acetyl-substituted pyridine derivative with 3-aminoacrolein, reacting reaction product with ammonia or ammonium salt
12/03/2002US6489344 For treatment diabetes in a human or animal subject
12/03/2002US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002CA2117543C Dipeptidylquinazolones as anti-cancer agents
12/03/2002CA2080705C Substituted pyrimidines
11/2002
11/28/2002WO2002094844A2 Antiviral nucleosides
11/28/2002WO2002094815A1 Process for the production of quinazolines
11/28/2002WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002WO2002094766A1 Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
11/28/2002WO2002073235A3 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
11/28/2002US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/28/2002CA2826505A1 Antiviral nucleosides
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2447671A1 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002CA2447233A1 Process for the production of quinazolines
11/28/2002CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002CA2446620A1 Antiviral nucleosides
11/27/2002EP1259486A1 Pyridine-amidines as modulators of p38 map kinase
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002EP0900023B1 Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators
11/27/2002EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002CN1094937C Farnesyltransferase inhibiting quinazolinones
11/27/2002CN1094929C Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/26/2002US6486178 Indane derivatives
11/26/2002US6485799 Aniline derivatives, liquid-crystal composition containing the same, and liquid-crystal display element